Investing Profile

Edward Van Wezel

InvestorVC
Managing Partner at BGV (BioGeneration Ventures)
Photo of Edward Van Wezel, Managing Partner at BGV (BioGeneration Ventures)
cb
$100K - $1M
$500K
7
€250M
CompanyStageDateRound SizeTotal Raised
Citryll
Series BDec 2024$90M
Series BJul 2020$21M
$110M
Co-investors: Geert-Jan Mulder (Forbion), Isabelle de Cremoux (Seventure Partners)
Confo Therapeutics
Series BJul 2024$65M
Series AMay 2019$34M
$99M
Azafaros
Series AFeb 2020$27M
SeedJul 2018
$27M
Co-investors: Sander Slootweg (Forbion)
Noviogendix Holding
Series UnknownJan 2007